Skip to main content
Clinical Trials/NCT04153942
NCT04153942
Withdrawn
Phase 3

Earlier Mobilization Post Acute Thrombolysis

Brian Silver0 sitesAugust 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Stroke
Sponsor
Brian Silver
Primary Endpoint
90 day mRS
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

This is a phase III trial trying to determine whether 12-hour bed rest following IV thrombolysis therapy (i.e. tPA) for ischemic stroke is non-inferior to 24-hour bed rest by measure of outcomes on the modified Rankin Scale (mRS) at 90 days post bed rest.

Registry
clinicaltrials.gov
Start Date
August 2023
End Date
December 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Brian Silver
Responsible Party
Sponsor Investigator
Principal Investigator

Brian Silver

Principal Investigator

University of Massachusetts, Worcester

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older
  • Received intravenous tPA for a clinical diagnosis of acute ischemic stroke
  • Patient and/or Legally Authorized Representative provide consent

Exclusion Criteria

  • Venous thromboembolism present at symptom onset
  • Pneumonia present at symptom onset
  • STEMI at symptom onset
  • Positive troponins at symptom onset according to local values
  • Bone fracture at symptom onset
  • Treatment includes or anticipated to include thrombectomy
  • Intubation anticipated or occurred
  • Symptomatic intracranial hemorrhage (defined as increase in NIHSS by 4 points or more accompanied by PH2 hemorrhage on imaging) at the time of screening.
  • Pre-screening systolic blood pressure \< 110 mmHg
  • Resting pulse oximetry \< 92% (with or without supplemental oxygen)

Outcomes

Primary Outcomes

90 day mRS

Time Frame: 90 days post bed rest

Proportion of patients with a modified Rankin Scale score (min 0, max 5 with 0 being best outcome) of 0-2 at 90 days

Secondary Outcomes

  • Pneumonia(Duration of hospitalization stay, average 5 days)
  • Venous Thromboembolism(Duration of hospitalization stay, average 5 days)
  • Neurological Worsening(Duration of hospitalization stay, average 5 days)
  • Length of Stay(Duration of hospitalization stay, average 5 days)
  • Readmission(90 days post bed rest)

Similar Trials